Articles from American Oncology Network

Annual revenue surpasses $2 billion for the 12 months ended June 30, 2025, reflecting >40% growth over the prior 12-month period. Provider network grows to >300 across 20 states. New treatment innovations broaden access to cutting-edge cancer care

FORT MYERS, Fla., July 24, 2025 (GLOBE NEWSWIRE) -- American Oncology Network (AON), one of the nation’s fastest-growing networks of community oncology practices, has received reaccreditation from the Accreditation Committee of the College of American Pathologists (CAP) for its Central Laboratory in Fort Myers, Florida. The recognition follows a recent on-site inspection conducted as part of the CAP’s Accreditation Programs.

AON community oncology practices across the nation offering groundbreaking immunotherapy to expand treatment options for hard-to-treat cancers

Several AON physicians and leaders shared new cancer research at one of oncology’s most influential gatherings

Six AON community oncology practice partners now offering radioligand therapeutics for prostate and neuroendocrine cancers

FORT MYERS, Fla., May 15, 2025 (GLOBE NEWSWIRE) -- American Oncology Network (AON), one of the nation’s fastest-growing community oncology networks, today announced the appointment of Joe Verschleiser as chief growth and performance officer.

FORT MYERS, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- American Oncology Network (AON), one of the nation’s fastest-growing community oncology networks, today announced the appointment of Terri Casey as chief human resources officer (CHRO).

Sakeer Hussain, MD, was honored for his dedication to advancing cancer policy at national and state levels during ASCO’s 2025 Advocacy Summit event

More than a dozen AON leaders to speak on panels focused on advocacy, innovation and access in independent community oncology

Strategic Thyme Care partnership strengthens AON’s leadership in value-based care innovation while improving patient experience and reducing costs

SigmaCore’s easy-to-use platform, LabVizor integrates complex pathology reports into a streamlined, comprehensive system to enhance efficiency for AON’s pathology and oncology labs

FORT MYERS, FL, Oct. 29, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (OTCQX: AONC), one of the fastest-growing oncology networks in the United States, has partnered with Vantage Health Technologies to enhance access to and delivery of exceptional cancer care. Vantage’s AI-enabled platform provides real-time health data for actionable insights and next-best-actions that can promote better patient experiences and outcomes, reduce provider burnout, and lower the cost of care. The platform also helps AON further enhance its Value-Based Care model in community oncology.

FORT MYERS, Fla., July 31, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (“AON” or the “Company”) (OTCQX: AONC), one of the fastest growing community-based oncology practices, announced today that the Company will release its second quarter 2024 financial results on Wednesday, August 14, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on the same day.

FORT MYERS, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- American Oncology Network, Inc.  (AON) (OTCQX: AONC), a rapidly-growing network of community-based oncology practices, today announced it has qualified to trade on the OTCQX® Best Market. AON previously traded on NASDAQ.

Board-certified medical oncologists Magali Van den Bergh, MD, Venkata Parsa, MD, and Shivtaj Mann, DO join the Cape Coral physician team

Veteran Financial Leader David Afshar will lead the company’s financial and operating strategy.

FORT MYERS, Fla., May 21, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (“AON” or the “Company”) (Nasdaq: AONC), a rapidly growing network of community-based oncology practices, announced today its decision to voluntarily delist its Class A common stock and warrants from The Nasdaq Capital Market ("Nasdaq"). The Company’s decision to delist its securities from Nasdaq was recommended to the Board of Directors (the "Board") of the Company by a Special Committee (the "Special Committee") of the Board comprised solely of independent directors.

First Quarter 2024 Highlights

FORT MYERS, Fla., May 14, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (“AON” or the “Company”) (Nasdaq: AONC), one of the fastest growing community-based oncology practices, announced today that the Company will change the release date of its first quarter 2024 financial results to Monday, May 20, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time the following day.

FORT MYERS, Fla., May 03, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (“AON” or the “Company”) (Nasdaq: AONC), a rapidly growing network of community-based oncology practices, announced today that Dave Gould will step down as Chief Financial Officer, effective May 17, 2024, to pursue other opportunities. AON has appointed David Afshar, a seasoned public company executive, to fulfill the responsibilities of interim Chief Financial Officer, effective May 20, 2024. AON has initiated a process for a new Chief Financial Officer.

FORT MYERS, Fla., April 30, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (“AON” or the “Company”) (Nasdaq: AONC), one of the fastest growing community-based oncology practices, announced today that the Company will release its first quarter 2024 financial results on Wednesday, May 15, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on the same day.

MACON, Ga., April 04, 2024 (GLOBE NEWSWIRE) -- Central Georgia Cancer Care is excited to announce their partnership with the American Oncology Network (AON) (Nasdaq: AONC), one of the nation’s fastest-growing networks of community-based oncology practices, to further strengthen their patient care and services by utilizing the network’s vast resources and expertise. 

Hawaii Cancer Care partners with American Oncology Network to continue delivering quality cancer care to the community.

FORT MYERS, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- March 28, 2024 – American Oncology Network, Inc. (NASDAQ: AONC), a leading oncology platform with an innovative model of physician-led, community-based oncology management, today announced financial results for the three- and twelve-month periods ended December 31, 2023.

Woodlands Cancer Institute opens three clinic locations that provide medical oncology, radiation oncology and hematology care to its patients.

FORT MYERS, Fla., March 06, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (“AON” or the “Company”) (Nasdaq: AONC), one of the fastest growing community-based oncology practices, announced today that the Company will release its fourth quarter and full year 2023 financial results on Thursday, March 28, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on the same day.

FORT MYERS, Fla., Feb. 26, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (“AON” or the “Company”) (Nasdaq: AONC), one of the fastest growing community-based oncology practices, announced today that company executives will participate at the Cowen Annual Health Care Conference in Boston on March 5, 2024. The AON management team will also be hosting a presentation at 2:10 PM Eastern Time and a live webcast will be accessible through the Investor Relations section of the Company’s website at https://investors.aoncology.com/. A replay of the webcast will be posted shortly after the presentation and will be available for a limited time following the event.

Bay Hematology Oncology joins the American Oncology Network.

Third Quarter 2023 Highlights

FORT MYERS, Fla., Oct. 25, 2023 (GLOBE NEWSWIRE) -- American Oncology Network, Inc. (“AON” or the “Company”) (Nasdaq: AONC), a rapidly growing network of community-based oncology practices, announced today that the Company will release its third quarter 2023 financial results on Tuesday, November 14, 2023, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on the same day.

FORT MYERS, Fla., Sept. 27, 2023 (GLOBE NEWSWIRE) -- American Oncology Network, Inc. (“AON” or the “Company”) (Nasdaq: AONC), a rapidly growing network of community-based oncology practices announced today that it will host an investor presentation webcast on Friday, September 29, 2023 at 8:00 am Eastern Time, with its Chief Executive Officer, Todd Schonherz and Chief Financial Officer, David Gould. During the presentation, management will walk through AON’s business model, growth strategy, and unique value proposition.

Since its founding, AON has expanded into 19 states and counting.

American Oncology Network expands into Texas with the opening of Lone Star Oncology.

AON physicians and leaders share their latest cancer findings with fellow thought leaders at the annual conference.

FORT MYERS, Fla., April 28, 2023 (GLOBE NEWSWIRE) -- American Oncology Network (“AON” or the “Company”), a rapidly growing network of community-based oncology practices, today announced that the Company has entered into a definitive agreement to receive a strategic growth investment from AEA Growth.

AON’s dedication to closing the cancer care gap is evident in its 2022 achievements.

AON announces the newest leadership to join the Board of Managers.

AON celebrates its Board of Managers’ appointments and retirements.

The partnership aims to accelerate the delivery of value-based care for cancer patients.

FORT MYERS, Fla., Dec. 21, 2022 (GLOBE NEWSWIRE) -- American Oncology Network, LLC (AON) announced today Brad Prechtl’s retirement as President and Chief Development Officer effective January 1, 2023. Prechtl will continue to serve as a special advisor to the network and its board after the new year.

FORT MYERS, Fla., Dec. 14, 2022 (GLOBE NEWSWIRE) -- American Oncology Network, LLC (AON) is pleased to announce that seven research studies co-authored by AON physicians were presented at the American Society of Hematology (ASH) Annual Meeting & Exposition, held December 10-13 in New Orleans, Louisiana.

FORT MYERS, Fla., Dec. 07, 2022 (GLOBE NEWSWIRE) -- American Oncology Network, LLC (AON), a high-growth medical oncology provider with a focus on supporting the long-term viability of community-based cancer care and treatments, announced today the appointment of Anthony Belott as AON’s new Chief Development Officer. Belott will succeed current President and Chief Development Officer Brad Prechtl, who will retire effective January 1, 2023. Prechtl will continue to serve as a special advisor to the network and its board after the new year.

Four AON physicians joined the American Cancer Society as ambassadors to raise money for the fight against breast cancer.